Kyverna Therapeutics KYTX
NASDAQ KYTX
$5.84 -0.20 (-3.31%)
At close: Oct 21, 2026 · 4:00 PM EDT

Kyverna Therapeutics (KYTX) Non-Current Debt (2025 - 2026)

Updated

Kyverna Therapeutics (KYTX) posted Non-Current Debt of $24.88 million for Q2 2026, up 0.3% from the prior quarter.

Analysis

Kyverna Therapeutics (KYTX) Non-Current Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Kyverna Therapeutics' Non-Current Debt came in at $24.74 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 37.34 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 62.48 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 23.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 23.83 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 60.50 Bn
10 Kyverna Therapeutics 356.25 Mn -530.13 Mn - 24.88 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.88 Mn
Mar 31, 2026 24.81 Mn
Dec 31, 2025 24.74 Mn
API Access

Kyverna Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=KYTX&period=max&api_key=YOUR_API_KEY